Prayus Tailor, MD
Nephrology · Newark, DENPI 1679552764
Payments from drug & device makers
Across 585 payments — averaging $217.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nxstage Medical, Inc.$82K
- AstraZeneca$13K
- Fresenius USA Marketing, Inc.$10K
- GSK$8K
- Aurinia Pharma U.S., Inc.$4K
- Bayer$3K
- plus $8K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nxstage Medical, Inc. | 99 | $81,536 |
| AstraZeneca(2 entities) | 63 | $13,209 |
| Fresenius USA Marketing, Inc. | 79 | $9,997 |
| GSK | 19 | $8,202 |
| Aurinia Pharma U.S., Inc. | 11 | $3,910 |
| Bayer | 28 | $2,774 |
| Amgen(2 entities) | 50 | $2,703 |
| Mallinckrodt Hospital Products Inc. | 29 | $811 |
| Vifor Pharma, Inc. | 29 | $674 |
| Otsuka America Pharmaceutical, Inc. | 28 | $548 |
| Travere Therapeutics, Inc. | 25 | $512 |
| Calliditas Therapeutics US Inc. | 16 | $415 |
| Novartis | 9 | $250 |
| Daiichi Sankyo Inc. | 14 | $244 |
| Ardelyx, Inc. | 12 | $239 |
| Sanofi | 11 | $194 |
| Akebia Therapeutics Inc | 9 | $164 |
| Novo Nordisk | 7 | $132 |
| Kyowa Kirin, Inc. | 5 | $117 |
| Boehringer Ingelheim | 7 | $111 |
| Mallinckrodt Enterprises LLC | 5 | $88 |
| Medtronic | 1 | $85 |
| ANI Pharmaceuticals, Inc. | 2 | $64 |
| Ultragenyx Pharmaceutical Inc. | 4 | $64 |
| OPKO Pharmaceuticals, LLC | 4 | $55 |
| Shield Therapeutics Inc | 1 | $55 |
| AMAG Pharmaceuticals, Inc. | 4 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Inari Medical, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $43 |
| Mozarc Medical US LLC | 1 | $38 |
| Scpharmaceuticals Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Daxor Corporation | 1 | $10 |
How this compares
$127,477 in reported general payments places this provider in the 95th percentile of 49 nephrology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Newark
- Theodore SaadNewark$696K
- William DahmsNewark$94K
- Nealanjon DasNewark$6K
- Manthodi FaisalNewark$6K
- Piyaporn ApivatanagulNewark$5K
- Lindsey SlaterNewark$4K
- Christopher CanfieldNewark$3K
- Farhana ChowdhuryNewark$3K
- Feroz Abubacker KaniyamparambilNewark$3K
- Carlos MachadoNewark$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.